About the 2026 C2C4C Ride
The inaugural C2C4C ride was held twelve years ago in the United States as Coast 2 Coast 4 Cancer. Riders in Europe joined the effort in 2016 for the Country 2 Country 4 Cancer, Japan in 2021 and Latin America in 2022 as the Continent 2 Continent 4 Cancer. Since 2021, more than USD 830,000 has been donated to charitable organisations in Asia Pacific via the C2C4C ride.
In this sixth edition, the 2026 C2C4C ride will feature over 55 Bristol Myers Squibb employees riding nearly 1,800 kilometres from 6-20 October. The 15-day event involves five teams each cycling a three-day segment. Five teams will feature riders participating from seven countries including Australia, China, India, Japan, Republic of Korea, Singapore, and the United States.
The mission of C2C4C is to raise awareness for cancer research and cancer organisations in the Asia Pacific region who are members of the UICC.
Raising Funds for Singapore Cancer Society (SCS)
Established in 1964, SCS supports people through every stage of the cancer journey, from well to end of life.
SCS minimises cancer and maximises lives by providing trusted information and care navigation, cancer screening and education, rehabilitation programmes, financial and welfare services, psychosocial and survivorship support, and home hospice care. Working together with healthcare, corporate, and community partners, SCS rallies the community to better support those affected by cancer.
Who Are the Riders
The participants are novice riders, who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. Their kilometers will help raise funds to fight against cancer by supporting SCS, member of the Union for International Cancer Control.
About BMS
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. For more information about Bristol Myers Squibb, visit us at bms.com/de or follow us on LinkedIn , Instagram , Twitter and YouTube .
About UICC
The Union for International Cancer Control (UICC) is the largest and oldest international cancer organisation dedicated to reducing the burden of cancer around the world. Founded in 1933, UICC has more than 1,150 members in over 170 countries and territories. UICC ’ s mission is both to unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity, and ensure that cancer control remains a priority on the global health and development agenda.
